Entering text into the input field will update the search result below

Cyclacel Pharmaceuticals reports Q1 results

May 11, 2016 4:20 PM ETCyclacel Pharmaceuticals, Inc. (CYCC) StockBy: Mohit Manghnani, SA News Editor
  • Cyclacel Pharmaceuticals (NASDAQ:CYCC): Q1 EPS of -$0.09
  • Cash and cash equivalents of $17.1M.
  • Press Release

Recommended For You

More Trending News

About CYCC Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CYCC--
Cyclacel Pharmaceuticals, Inc.